Cepacol
- Product NDC
- 63824-744
- 11-digit product format
- 638240744
- Labeler code
- 63824
- Product ID
- 63824-744_51b5d087-def6-54b3-e063-6294a90ac9ad
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- BENZOCAINE and DEXTROMETHORPHAN HYDROBROMIDE
- Dosage form
- LOZENGE
- Route
- ORAL
- Labeler
- Reckitt Benckiser LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-05-05
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; BENZOCAINE
- Active strength
- 5; 7.5 mg/1; mg/1
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63824-744 | 63824-744-36 | D | Discontinued by firm | 2026-10-21 | |
| excluded package | package | 63824-744 | 63824-744-94 | D | Discontinued by firm | 2026-10-21 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 63824-744-94 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 63824-744-36 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 63824-744-94 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 63824-744-36 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 63824-744-36 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 63824-744-94 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 63824-744-36 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 63824-744-94 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 63824-744-36 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 63824-744-94 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 63824-744-94 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 63824-744-36 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 63824-744-94 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 63824-744-36 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 63824-744-94 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 63824-744-36 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 63824-744-94 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 63824-744-36 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 63824-744-94 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 63824-744-36 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 63824-744-94 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 63824-744-36 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 63824-744-94 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 63824-744-36 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cepacol
- Brand name suffix
- Extra Strength Sore Throat and Cough
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 5 mg/1 |
| BENZOCAINE | 7.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9D2RTI9KYH | Internal UNII lookup |
| U3RSY48JW5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c0cc32db-90f0-4106-8538-89821083ece1 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fb7ab793-2c12-4079-b100-a64f73bef25a | Product name | 4 | 20240712 |
| b0cbf770-6cc3-4aa4-9158-755110c2b9f7 | Product name | 2 | 20230717 |
| dc7c5daa-021f-40dd-b00d-63982cb2067a | Product name | 1 | 20230426 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 5 | 20200925 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 2 | 20160823 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63824-744-16 | CepacolExtra Strength Sore Throat and Cough | 8 in 1 BLISTER PACK | LOZENGE | 8 | 14 | |
| 63824-744-16 | CepacolExtra Strength Sore Throat and Cough | 2 in 1 CARTON | LOZENGE | 2 | 14 | |
| 63824-744-36 | CepacolExtra Strength Sore Throat and Cough | 3 in 1 CARTON | LOZENGE | 3 | 14 | |
| 63824-744-36 | CepacolExtra Strength Sore Throat and Cough | 12 in 1 BLISTER PACK | LOZENGE | 12 | 14 | |
| 63824-744-94 | CepacolExtra Strength Sore Throat and Cough | 4 in 1 BLISTER PACK | LOZENGE | 4 | 14 | |
| 63824-744-94 | CepacolExtra Strength Sore Throat and Cough | 1 in 1 CARTON | LOZENGE | 1 | 14 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63824-744-16 | EA - Each | 63824-744 | 7cd08d15-6f23-4040-a102-e5213cd34025 | 1 | 2019-03-12 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63824-744 | CEPACOL EXTRA STRENGTH SORE THROAT AND COUGH (BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE) LOZENGE [RB HEALTH (US) LLC] | 10 | Current NDC, Legacy NDC, 6 package rows | 20250323_c0cc32db-90f0-4106-8538-89821083ece1.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Honey Lemon Cough Drops | MENTHOL | CVS Pharmacy | de963dc3-8108-440f-e053-2995a90a906f | 2026-01-16 | Warnings | M012 |
| CVS SF Menthol Cough Drops | MENTHOL | CVS Pharmacy | e08f8ca3-b683-4964-e053-2a95a90afabb | 2026-01-16 | Warnings | M012 |
| CVS SF Honey Lemon Cough Drops | MENTHOL | CVS Pharmacy | e0cdeccf-c32f-318a-e053-2a95a90ac401 | 2026-01-16 | Warnings | M012 |
| Mixed Berry Throat and Cough Lozenges | BENZOCAINE | CVS Pharmacy | 737b1c88-1a44-68cf-e053-2991aa0a35b6 | 2026-01-16 | Warnings | M012 |
| Walgreens Wild Cherry Throat Drops | PECTIN | Walgreens | 4885eca3-c1e9-8350-e063-6394a90ac290 | 2026-01-16 | Warnings | M012 |
| HBP Chest Congestion and Cough Relief | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Walgreens | ff7a1462-9994-4421-85aa-c03488bb04cf | 2026-01-16 | Warnings | M012 |
| Cough Relief | DEXTROMETHORPHAN HBR | WALGREEN COMPANY | a793acbc-107c-4638-a2d7-65f4e96cafda | 2026-01-16 | Warnings | M012 |
| MUCUS RELIEF DM | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Walgreens | ca53ec26-d167-1780-e053-2a95a90a5b88 | 2026-01-16 | Warnings | M012 |
| Maximum Strength Congestion and Headache | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Walgreens | 88da92d2-92c2-445a-9b70-58996e086014 | 2026-01-16 | Warnings | M012 |
| Maximum Strength Cold and Flu | ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Walgreens | 5f638bca-55c2-4ead-8c47-3f15713495da | 2026-01-16 | Warnings | M012 |
| COLD, Flu and Sore Throat | ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Walgreens | 190175bb-c08a-4050-aacf-29a130cbe05c | 2026-01-16 | Warnings | M012 |
| Night Time Cold and Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | FSA Store Inc. (Caring Mills) | a9bd1efc-51c7-40d0-a4f8-f130ce5b45ff | 2026-01-16 | Warnings | M012 |
| Allergy Multi-Symptom | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | L.N.K. International, Inc. | 99147338-f459-4423-ae54-f96fffc1728d | 2026-01-15 | Warnings | M012 |
| SanaTos Severe Cold Relief Nighttime | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Pharmadel LLC | 144aafcc-6ec2-a322-e063-6294a90afc27 | 2026-01-15 | Warnings | M012 |
| SanaTos Severe Cold and Cough Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | Pharmadel LLC | 14484bf5-ff45-b859-e063-6394a90a9a0f | 2026-01-15 | Warnings | M012 |
| Foster and Thrive Chest Congestion Relief PE PE | GUAIFENESIN/PHENYLEPHRINE | Strategic Sourcing Services LLC | 3429aedc-e83d-498a-bfca-03aaf5847b3b | 2026-01-15 | Warnings | M012 |
| Quality Choice Allergy Relief | DIPHENHYDRAMINE HYDROCHLORIDE | Chain Drug Marketing Association | 4b86101c-00f8-4ede-807f-db4273b37b8d | 2026-01-15 | Warnings | M012 |
| Quality Choice Mucus Relief DM DM | DEXTROMETHORPHAN HYDROBROMIDE / GUAIFENESIN | Chain Drug Marketing Association | d1ba7267-6844-4a14-b518-65277a32e855 | 2026-01-15 | Warnings | M012 |
| ACTINEL DM Pediatric | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | ACTIPHARMA, LLC | f85d8586-423f-48a3-9bb2-bbc5984c7cd3 | 2026-01-15 | Warnings | M012 |
| ACTINEL Diabetic | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | ACTIPHARMA, LLC | 35c21623-84dd-4151-b35b-e7d30b69c9c0 | 2026-01-15 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1039255 | Cepacol Sore Throat Plus Cough 7.5 MG / 5 MG Oral Lozenge | PSN | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
| 1039251 | dextromethorphan HBr 5 MG / benzocaine 7.5 MG Oral Lozenge | PSN | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
| 1039255 | benzocaine 7.5 MG / dextromethorphan hydrobromide 5 MG Oral Lozenge [Cepacol Sore Throat Plus Cough] | SBD | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
| 1039251 | benzocaine 7.5 MG / dextromethorphan hydrobromide 5 MG Oral Lozenge | SCD | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
| 1039255 | Cepacol Sore Throat Plus Cough (benzocaine 7.5 MG / dextromethorphan hydrobromide 5 MG) Oral Lozenge | SY | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63824-744-16 | 63824074416 | 2 BLISTER PACK in 1 CARTON (63824-744-16) / 8 LOZENGE in 1 BLISTER PACK | 2 blister pack | 2014-05-05 | 0000-00-00 | No | No | Current |
| 63824-744-36 | 63824074436 | 3 BLISTER PACK in 1 CARTON (63824-744-36) > 12 LOZENGE in 1 BLISTER PACK | 3 blister pack | 2019-05-01 | 0000-00-00 | No | No | Current |
| 63824-744-94 | 63824074494 | 1 BLISTER PACK in 1 CARTON (63824-744-94) > 4 LOZENGE in 1 BLISTER PACK | 1 blister pack | 2014-05-05 | 0000-00-00 | No | No | Current |